AKT1 and hepatocellular carcinoma: Since the choice of appropriate animal models is particularly relevant in order to assess novel molecularly-based therapeutic strategies [25], the authors chose a hydrodynamic tail vein injection of Akt and β-catenin oncogenes to induce HCC in mice, mirroring this subgroup of human tumors.